CARDIOVASCULAR SYSTEMS INC (CSII)       13.815  -0.91 (-6.15%)

13.815  -0.91 (-6.15%)

US1416191062 - Common Stock

Full estimates are only available for subscribed users, you can see which data is available below.

Registered users have access to more data. Please register or login for additional estimates.

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates


2020 2021 2022 2023 2024 2025
Revenue
236.5M
-4.64%		258.973M
9.50%		236.222M
-8.79%		263.81M
11.68%
EBITDA
-22.62M
-953.58%		-7.621M
66.31%		-30.777M
-303.84%		-3.213M
89.56%
EBIT
-26.8M
-3,250.00%		-11.933M
55.47%		-35.806M
-200.06%		-27.954M
21.93%
Operating Margin
-11.33%-4.61%-15.16%-10.60%
EPS
-0.78
-3,800.00%		-0.26
66.67%		-0.95
-265.38%		-0.69
27.10%

All data in USD


Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates


Q1 / 23 Q2 / 23 Q3 / 23 Q4 / 23 Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS-0.23
-6.64%		-0.16
32.21%
Revenue60.328M
3.35%		64.341M
8.80%
EBITDA-3.407M-46.583K
EBIT-8.656M
-6.67%		-6.137M
28.29%

All data in USD


EPS and Revenue Surprises


Recent Earnings VS Estimates (USD)
Period Reported Estimate Difference Surprise Q1 2023 -0.27 -0.23 -0.04-15.09% Q4 2022 -0.25 -0.22 -0.03-12.26% Q3 2022 -0.25 -0.29 0.0413.04% Q2 2022 -0.23 -0.14 -0.09-63.99% Q1 2022 -0.22 -0.12 -0.10-90.32% Q4 2021 -0.14 -0.17 0.0317.65% Q3 2021 -0.07 -0.10 0.0328.59% Q2 2021 0.00 -0.07 0.07100.00%
Recent Revenue VS Estimates (USD)
Period Reported Estimate Difference Surprise Q1 2023 59.673M 60.328M -655K-1.09% Q4 2022 62.496M 64.226M -1.73M-2.69% Q3 2022 56.221M 58.527M -2.306M-3.94% Q2 2022 59.135M 64.433M -5.298M-8.22% Q1 2022 58.37M 65.556M -7.186M-10.96% Q4 2021 70.987M 70.201M 786K1.12% Q3 2021 63.27M 64.38M -1.11M-1.72% Q2 2021 64.17M 66.825M -2.655M-3.97%

EPS and Revenue Revisions


Next Q (1 month)Next Q (3 month)Next Year (1 month)Next Year (3 month)
EPSN/A N/A 0% -2.35%
RevenueN/A N/A 0% 0.06%